Corydalis crispa
Corydalis crispa · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Corydalis crispa is a medicinal plant recognized for its significant anthelmintic activities against various biological threats. Research has identified key bioactive chemicals within the plant, including 13-Oxocryptopine, Bergapten, Coreximine, and Isomyristicin. These compounds are frequently studied through the use of crude extracts to evaluate their therapeutic potential. Scientific investigations focus on the plant's ability to address complex conditions such as autoimmunity, cancer, and diverse infectious diseases. Notably, its effectiveness has been specifically highlighted in targeting the parasite Schistosoma mansoni.
- Synonyms
- Not available
- Common names
- Not available
- Family
- Papaveraceae
- Distribution
- Africa
- Plant Parts
- Not available
Classification
Taxonomy
Corydalis crispa belongs to the vast kingdom Plantae, representing the diverse world of living vegetation. Within this biological realm, the plant is classified under the class Equisetopsida. It further resides in the order Ranunculales, a group that highlights its evolutionary lineage. As a member of the genus Corydalis, it shares distinct morphological traits with its close relatives. Finally, this species is nested within the family Papaveraceae, connecting it to the broader poppy family.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Ranunculales |
| Family | Papaveraceae |
| Genus | Corydalis |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Corydalis crispa is a botanical species with a diverse geographic range spanning several distinct regions. In the temperate zones of Asia, its distribution is notably concentrated within China and Tibet. Moving into tropical climates, the plant also flourishes across the Indian Subcontinent. Furthermore, it can be found nestled within the unique ecosystems of the East Himalaya. This wide-reaching presence highlights the plant's ability to adapt to varied environmental conditions across the continent.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Corydalis crispa is a self-supporting herb characterized by its distinct growth form. This plant typically maintains a modest stature, reaching a maximum height of 0.5 meters. Depending on its environment, its size can vary, with minimum heights often measured around 0.2 meters. In many instances, the plant stabilizes at a slightly taller minimum of 0.35 meters. Understanding these physical dimensions is essential for identifying this species in the wild.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Corydalis crispa serves as a vital source of medicinal compounds that exhibit significant anthelmintic properties. In recent studies, phytochemicals isolated from this Bhutanese plant were investigated for their ability to combat neglected tropical diseases such as schistosomiasis and trichuriasis. Specifically, compounds like isomyristicin and bergapten were identified as effective agents against blood flukes and whipworms. These substances work by inducing physical damage to the parasites, affecting their tegument or cuticle to disrupt their survival. Ultimately, the bioactive elements found in Corydalis crispa offer promising new scaffolds for the development of broad-spectrum drugs to control helminth infections in both humans and animals.
Compounds
Corydalis crispa is a Bhutanese medicinal plant that serves as a rich source of various bioactive isoquinoline alkaloids. Comprehensive phytochemical investigations have confirmed that the plant contains several key compounds, including 13-oxocryptopine, coreximine, and ochrobirine. Furthermore, the presence of bergapten and isomyristicin within its chemical profile has significant therapeutic implications. These specific constituents have demonstrated notable anthelmintic activity against parasites such as Schistosoma mansoni and Trichuris muris. Ultimately, the diverse chemical makeup of Corydalis crispa provides a strong scientific foundation for its traditional use in treating a wide range of medical disorders.
Conditions
Corydalis crispa demonstrates significant therapeutic potential by treating the multidrug-resistant P. falciparum strains TM4/8.2 and K1CB1. The plant also provides effective anthelmintic action against the parasite Schistosoma mansoni. Furthermore, its extracts are capable of treating TNF-alpha production in LPS activated THP-1 cells. Research indicates that the plant can treat Trichuris muris through the action of specific isolated phytochemicals. Finally, the immunomodulatory properties of its compounds suggest a capacity to treat autoimmunity.
Preparations
Corydalis crispa is prepared as crude extracts to investigate its chemical constituents and biological activities. These crude extracts were specifically developed using four different solvents, including methanol, hexane, dichloromethane, and chloroform. Research demonstrates that these extracts exhibit significant anti-inflammatory activity by inhibiting TNF-alpha production in LPS-activated THP-1 cells. Among the seven Bhutanese medicinal plants studied, the crude extracts of Corydalis crispa provided the most potent inhibitory activity. This method of preparation serves to validate the plant's traditional use in Bhutanese medicine for managing various inflammatory disorders.